[淋巴结阳性阴茎癌：管理与全身治疗]
[Lymph-node-positive penile cancer : Management and systemic therapy].
作者信息
Aziz A, Milerski S, Kernig K, Protzel C, Hakenberg O W
机构信息
Klinik und Poliklinik für Urologie, Universitätsmedizin Rostock, Schillingallee 35, 18057, Rostock, Deutschland.
Klinik für Urologie, Helios-Klinikum Schwerin, Schwerin, Deutschland.
出版信息
Urologe A. 2018 Apr;57(4):440-443. doi: 10.1007/s00120-018-0601-y.
Cancer-specific survival in men with penile cancer depends foremost on regional lymphatic metastasis and its extent. Patients with limited inguinal lymph node metastases have a 5-year survival of up to 80%. However, those with pelvic lymph node metastases and/or systemic disease have a 5-year survival prognosis of only 0-33%. In any case, in patients with regional lymph node metastases multimodal treatment with complete lymphadenectomy and adjuvant chemotherapy is indicated.
阴茎癌男性患者的癌症特异性生存主要取决于区域淋巴结转移及其范围。腹股沟淋巴结转移受限的患者5年生存率高达80%。然而，有盆腔淋巴结转移和/或全身性疾病的患者5年生存预后仅为0 - 33%。无论如何，对于有区域淋巴结转移的患者，建议采用包括根治性淋巴结清扫术和辅助化疗的多模式治疗。
Zotero 插件